NCT06162663 2026-02-27
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
Medical University of South Carolina
Phase 4 Terminated
Clinical Trials
6 trialsNCT05732064 2025-07-31
Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality
Peking University First Hospital
Phase 4 Completed
NCT06834386 2025-05-01
Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients
Mayo Clinic
Phase 4 Withdrawn
NCT02807922 2021-07-16
Pharmacological Treatment of Insomnia in Palliative Care
St. Olavs Hospital
Phase 4 Completed
NCT00365261 2016-07-11
Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer
University of California, San Diego
Phase 4 Completed
NCT00337272 2011-08-22
Treating Chronic Insomnia in Breast Cancer Patients
Accelerated Community Oncology Research Network
Phase 4 Terminated